Jupiter Neurosciences, Inc. (JUNS) vs OSR Health, Inc. (OSRH)

Jupiter Neurosciences, Inc. and OSR Health, Inc. are both Biotechnology companies. Jupiter Neurosciences, Inc. and OSR Health, Inc. are of similar size ($4.1M and $4.1M). Jupiter Neurosciences, Inc. has the higher net margin (0.00% vs −1,093.4%) and the higher return on invested capital (0.00% vs −8.19%). Across the 12 metrics below, Jupiter Neurosciences, Inc. leads on 6 and OSR Health, Inc. on 6.

Valuation

Metric JUNS OSRH Biotechnology median
P/E n/m n/m 8.50
P/S n/m 4.00 9.71
P/B n/m 0.06 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 6.17 9.21
Earnings yield (656.97%) (168.18%) (33.15%)
Free cash flow yield (446.77%) (105.52%) (25.50%)

Profitability

Metric JUNS OSRH Biotechnology median
Gross margin — 35.29% 65.16%
Operating margin 0.00% (933.72%) 0.00%
Net margin 0.00% (1,093.41%) 0.00%
Free cash flow margin 0.00% (398.26%) 0.00%
Return on equity (1,888.80%) (14.98%) (56.36%)
Return on assets (239.36%) (11.24%) (48.04%)
Return on invested capital 0.00% (8.19%) 0.00%

Growth

Metric JUNS OSRH Biotechnology median
Revenue growth (TTM) — (50.24%) 6.02%
EPS growth (last fiscal year) (212.50%) 71.07% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric JUNS OSRH Biotechnology median
Debt to equity 0.00 0.04 0.00
Current ratio 0.66 0.18 4.72
Net debt to EBITDA 0.43 (0.29) 0.96

Dividend

Metric JUNS OSRH Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric JUNS OSRH Biotechnology median
Market cap 4.14m 4.09m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack